Ann Clin Microbiol 2023;26:147-157. Analysis of blood culture data at a university hospital: bacterial distribution and cumulative antimicrobial resistance (2016–2020)
Table 5. Antimicrobial resistance rates of A. baumannii and P. aeruginosa blood isolates during 2016-2020
% Resistant
20162017201820192020Total
A. baumannii (n = 89)(n = 80)(n = 57)(n = 55)(n = 67)(n = 348)
Ampicillin/sulbactam*37.1 32.0 36.0 54.5 56.3 43.6
Ceftazidime61.4 62.0 74.0 80.0 78.1 70.9
Cefepime64.3 64.0 74.0 83.6 76.6 72.3
Imipenem64.3 70.0 74.0 83.6 71.9 72.3
Meropenem64.3 70.0 76.0 83.6 73.4 73.0
Ciprofloxacin62.9 70.0 76.0 83.6 78.1 73.7
Gentamicin54.3 54.0 54.0 54.5 46.9 52.6
P. aeruginosa (n = 27)(n = 36)(n = 39)(n = 46)(n = 49)(n = 197)
Piperacillin/tazobactam13.6 14.7 10.8 22.7 26.1 18.6
Ceftazidime13.6 8.8 8.1 15.9 23.4 14.7
Cefepime4.5 5.9 13.5 13.6 23.4 13.6
Imipenem22.7 8.8 24.3 18.2 38.3 23.4
Meropenem18.2 5.9 18.9 15.9 31.9 19.0
Ciprofloxacin*9.1 2.9 21.6 22.731.919.6

*P < 0.05.